IHH Healthcare Stock

Equities

IHH

MYL5225OO007

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-21 pm EDT 5-day change 1st Jan Change
6.15 MYR +0.49% Intraday chart for IHH Healthcare +1.99% +1.99%
Sales 2024 * 22.1B 4.63B Sales 2025 * 23.64B 4.95B Capitalization 54.16B 11.34B
Net income 2024 * 1.73B 363M Net income 2025 * 1.92B 403M EV / Sales 2024 * 2.76 x
Net Debt 2024 * 6.85B 1.44B Net Debt 2025 * 6.5B 1.36B EV / Sales 2025 * 2.57 x
P/E ratio 2024 *
30.9 x
P/E ratio 2025 *
28.2 x
Employees 65,000
Yield 2024 *
1.3%
Yield 2025 *
1.4%
Free-Float 24.08%
More Fundamentals * Assessed data
Dynamic Chart
IHH Healthcare Names CFO MT
IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer CI
Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Director, Effective March 31, 2024 CI
Ihh Healthcare Berhad Appoints Yoichiro Endo as Non Independent and Non Executive Director CI
Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Member of Nomination and Remuneration Committee CI
Ihh Healthcare Berhad Appoints Yoichiro Endo as Non Independent and Non Executive Member of Nomination and Remuneration Committee CI
IHH Healthcare Seeks Shareholder Approval for Buyback Program MT
IHH Healthcare Issues New Shares Pursuant to Exercise of Options MT
Transcript : IHH Healthcare Berhad, Q4 2023 Earnings Call, Mar 01, 2024
Ihh Healthcare Berhad Announces Final Single Tier Cash Dividend for the Financial Year Ended 31 December 2023, Payable on 26 April 2024 CI
IHH Healthcare Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 CI
IHH Healthcare Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
IHH Healthcare Withdraws IPO Plans for Indian Lab DJ
IHH Healthcare Indirect Unit's Subsidiary Scraps Proposed India IPO MT
IHH Healthcare's MYR245 Million Acquisition of Bedrock Healthcare Becomes Unconditional MT
More news
1 day+0.49%
1 week+0.99%
Current month+1.65%
1 month+1.99%
3 months+2.50%
6 months+3.36%
Current year+1.99%
More quotes
1 week
6.02
Extreme 6.02
6.16
1 month
5.93
Extreme 5.93
6.17
Current year
5.93
Extreme 5.93
6.25
1 year
5.64
Extreme 5.64
6.25
3 years
5.12
Extreme 5.12
7.34
5 years
4.55
Extreme 4.55
7.34
10 years
3.85
Extreme 3.85
7.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 23-09-30
Investor Relations Contact - -
Corporate Officer/Principal 58 21-04-30
Members of the board TitleAgeSince
Director/Board Member 67 12-01-23
Chairman 67 11-03-29
Director/Board Member 64 20-12-31
More insiders
Date Price Change Volume
24-04-22 6.15 +0.49% 6,007,000
24-04-19 6.12 +0.49% 3,874,900
24-04-18 6.09 0.00% 3,481,700
24-04-17 6.09 -0.16% 5,294,500
24-04-16 6.1 +1.16% 3,682,200

End-of-day quote BURSA MALAYSIA, April 21, 2024

More quotes
IHH Healthcare Berhad is a Malaysia-based integrated healthcare provider. The Company's segments include Hospital and Healthcare, IMU Health, Labs, PLife REIT and Others. It operates its Hospital and Healthcare segment in Singapore, Malaysia, India, Greater China, Turkey and Europe and Southeast Asia. The IMU Health segment is engaged in providing educational services. The Labs segment provides diagnostic laboratory services. The PLife REIT segment is a real estate investment trust. Through its portfolio of brands, such as Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway, the Company offers its patients comprehensive and personalized care ranging from primary to quaternary, and even ancillary services such as laboratory, diagnostics, imaging, and rehabilitation. It provides day-to-day healthcare services through outpatient treatment, routine check-ups, and vaccinations. Its secondary care comprises specialist consultation, local surgeries, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
6.15 MYR
Average target price
7.13 MYR
Spread / Average Target
+15.94%
Consensus